Cargando…

Therapeutic modulation of eIF2α-phosphorylation rescues TDP-43 toxicity in amyotrophic lateral sclerosis disease models

Amyotrophic lateral sclerosis (ALS) is a fatal, late-onset neurodegenerative disease primarily impacting motor neurons. A unifying feature of many proteins associated with ALS, including TDP-43 and Ataxin-2, is that they localize to stress granules. Unexpectedly, we found that genes that modulate st...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Hyung-Jun, Raphael, Alya R., LaDow, Eva S., McGurk, Leeanne, Weber, Ross, Trojanowski, John Q., Lee, Virginia M.-Y., Finkbeiner, Steven, Gitler, Aaron D., Bonini, Nancy M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2013
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3934366/ https://www.ncbi.nlm.nih.gov/pubmed/24336168 http://dx.doi.org/10.1038/ng.2853

Ejemplares similares

TDP-43, a protein central to amyotrophic lateral sclerosis, is destabilized by tankyrase-1 and -2
por: McGurk, Leeanne, et al.
Publicado: (2020)

Poly(ADP-ribose) Engages the TDP-43 Nuclear-Localization Sequence to Regulate Granulo-Filamentous Aggregation
por: McGurk, Leeanne, et al.
Publicado: (2018)

TDP-43 and Phosphorylated TDP-43 Levels in Paired Plasma and CSF Samples in Amyotrophic Lateral Sclerosis
por: Ren, Yuting, et al.
Publicado: (2021)

Protein interacting with C kinase (PICK1) is a suppressor of spinocerebellar ataxia 3-associated neurodegeneration in Drosophila
por: McGurk, Leeanne, et al.
Publicado: (2012)

Phosphorylated TDP-43 (pTDP-43) aggregates in the axial skeletal muscle of patients with sporadic and familial amyotrophic lateral sclerosis
por: Cykowski, Matthew D., et al.
Publicado: (2018)

Phosphorylated TDP-43 aggregates in peripheral motor nerves of patients with amyotrophic lateral sclerosis
por: Riva, Nilo, et al.
Publicado: (2022)

Monomerization of TDP-43 is a key determinant for inducing TDP-43 pathology in amyotrophic lateral sclerosis
por: Oiwa, Kotaro, et al.
Publicado: (2023)

Spread of pathology in amyotrophic lateral sclerosis: assessment of phosphorylated TDP-43 along axonal pathways
por: Fatima, Manaal, et al.
Publicado: (2015)

TDP-43—The key to understanding amyotrophic lateral sclerosis
por: Xu, Zuoshang, et al.
Publicado: (2014)

The role of TDP-43 mislocalization in amyotrophic lateral sclerosis
por: Suk, Terry R., et al.
Publicado: (2020)

Regulation of TDP-43 phosphorylation in aging and disease
por: Eck, Randall J., et al.
Publicado: (2021)

TDP-43 protein variants as biomarkers in amyotrophic lateral sclerosis
por: Williams, Stephanie M., et al.
Publicado: (2017)

Clinical Significance of TDP-43 Neuropathology in Amyotrophic Lateral Sclerosis
por: Cykowski, Matthew D., et al.
Publicado: (2017)

TDP‐43 as structure‐based biomarker in amyotrophic lateral sclerosis
por: Beyer, Léon, et al.
Publicado: (2020)

Intracellular Conformation of Amyotrophic Lateral Sclerosis-Causative TDP-43
por: Kitamura, Akira, et al.
Publicado: (2023)

Antibody against TDP-43 phosphorylated at serine 375 suggests conformational differences of TDP-43 aggregates among FTLD–TDP subtypes
por: Neumann, Manuela, et al.
Publicado: (2020)

TDP-43 Is Not a Common Cause of Sporadic Amyotrophic Lateral Sclerosis
por: Guerreiro, Rita J., et al.
Publicado: (2008)

Molecular Mechanisms of TDP-43 Misfolding and Pathology in Amyotrophic Lateral Sclerosis
por: Prasad, Archana, et al.
Publicado: (2019)

TDP-43–specific Autoantibody Decline in Patients With Amyotrophic Lateral Sclerosis
por: Nielsen, Anne Kallehauge, et al.
Publicado: (2020)

TDP-43 and Inflammation: Implications for Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
por: Bright, Fiona, et al.
Publicado: (2021)

Old age amyotrophic lateral sclerosis and limbic TDP‐43 pathology
por: Murakami, Aya, et al.
Publicado: (2022)

TDP-43 dysregulation and neuromuscular junction disruption in amyotrophic lateral sclerosis
por: Lépine, Sarah, et al.
Publicado: (2022)

Slow motor neurons resist pathological TDP-43 and mediate motor recovery in the rNLS8 model of amyotrophic lateral sclerosis
por: Hur, Seong Kwon, et al.
Publicado: (2022)

The pathogenic mechanism of TAR DNA-binding protein 43 (TDP-43) in amyotrophic lateral sclerosis
por: Wang, Xinxin, et al.
Publicado: (2023)

Microglial CD68 and L-ferritin upregulation in response to phosphorylated-TDP-43 pathology in the amyotrophic lateral sclerosis brain
por: Swanson, Molly E. V., et al.
Publicado: (2023)

Classification of FTLD-TDP cases into pathological subtypes using antibodies against phosphorylated and non-phosphorylated TDP43
por: Tan, Rachel H, et al.
Publicado: (2013)

Inhibition of RNA lariat debranching enzyme suppresses TDP-43 toxicity in ALS disease models
por: Armakola, Maria, et al.
Publicado: (2012)

Nuclear poly(ADP-ribose) activity is a therapeutic target in amyotrophic lateral sclerosis
por: McGurk, L., et al.
Publicado: (2018)

Nucleolin Rescues TDP-43 Toxicity in Yeast and Human Cell Models
por: Peggion, Caterina, et al.
Publicado: (2021)

Novel Mutations in TARDBP (TDP-43) in Patients with Familial Amyotrophic Lateral Sclerosis
por: Rutherford, Nicola J., et al.
Publicado: (2008)

Systemic dysregulation of TDP-43 binding microRNAs in amyotrophic lateral sclerosis
por: Freischmidt, Axel, et al.
Publicado: (2013)

TDP-43 pathology in the basal forebrain and hypothalamus of patients with amyotrophic lateral sclerosis
por: Cykowski, Matthew D, et al.
Publicado: (2014)

Mass spectrometric analysis of accumulated TDP-43 in amyotrophic lateral sclerosis brains
por: Kametani, Fuyuki, et al.
Publicado: (2016)

Pathological Modification of TDP-43 in Amyotrophic Lateral Sclerosis with SOD1 Mutations
por: Jeon, Gye Sun, et al.
Publicado: (2018)

Why TDP-43? Why Not? Mechanisms of Metabolic Dysfunction in Amyotrophic Lateral Sclerosis
por: Floare, Mara-Luciana, et al.
Publicado: (2020)

Impaired NHEJ repair in amyotrophic lateral sclerosis is associated with TDP-43 mutations
por: Konopka, Anna, et al.
Publicado: (2020)

A Commentary on TDP-43 and DNA Damage Response in Amyotrophic Lateral Sclerosis
por: Mitra, Joy, et al.
Publicado: (2019)

Distinct responses of neurons and astrocytes to TDP-43 proteinopathy in amyotrophic lateral sclerosis
por: Smethurst, Phillip, et al.
Publicado: (2020)

Cerebral atrophy in amyotrophic lateral sclerosis parallels the pathological distribution of TDP43
por: Dadar, Mahsa, et al.
Publicado: (2020)

Loss of TDP-43 function contributes to genomic instability in amyotrophic lateral sclerosis
por: Fang, Minggang, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_rmfbg2b22jp8s5uso7dmj1ukbd